<SEC-DOCUMENT>0001299265-16-000008-index.html : 20160628
<SEC-HEADER>0001299265-16-000008.hdr.sgml : 20160628
<ACCEPTANCE-DATETIME>20160628143225
ACCESSION NUMBER:		0001299265-16-000008
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20160628
DATE AS OF CHANGE:		20160628
GROUP MEMBERS:		MARK NORDLICHT
GROUP MEMBERS:		PLATINUM LIQUID OPPORTUNITY MANAGEMENT (NY) LLC
GROUP MEMBERS:		PLATINUM MANAGEMENT (NY) LLC
GROUP MEMBERS:		PLATINUM PARTNERS LIQUID OPPORTUNITY MASTER FUND L.P

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NAVIDEA BIOPHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0000810509
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				311080091
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-43603
		FILM NUMBER:		161735742

	BUSINESS ADDRESS:	
		STREET 1:		5600 BLAZER PARKWAY
		STREET 2:		SUITE 200
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017
		BUSINESS PHONE:		6147937500

	MAIL ADDRESS:	
		STREET 1:		5600 BLAZER PARKWAY
		STREET 2:		SUITE 200
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NEOPROBE CORP
		DATE OF NAME CHANGE:	19940714

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Platinum Partners Value Arbitrage Fund, LP
		CENTRAL INDEX KEY:			0001299265
		IRS NUMBER:				141861954
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		250 WEST 55TH STREET
		STREET 2:		14TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
		BUSINESS PHONE:		212-582-2222

	MAIL ADDRESS:	
		STREET 1:		250 WEST 55TH STREET
		STREET 2:		14TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>d13v4.htm
<TEXT>
Document 1 - file: d13v4.htm

</DOCUMENT>
</SEC-DOCUMENT>